M. C. Markowski Et Al. , "Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial," NATURE COMMUNICATIONS , vol.15, no.1, 2024
Markowski, M. C. Et Al. 2024. Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. NATURE COMMUNICATIONS , vol.15, no.1 .
Markowski, M. C., Taplin, M., Aggarwal, R., Sena, L. A., Wang, H., Qi, H., ... Lalji, A.(2024). Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial. NATURE COMMUNICATIONS , vol.15, no.1.
Markowski, Mark Et Al. "Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial," NATURE COMMUNICATIONS , vol.15, no.1, 2024
Markowski, Mark C. Et Al. "Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial." NATURE COMMUNICATIONS , vol.15, no.1, 2024
Markowski, M. C. Et Al. (2024) . "Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial." NATURE COMMUNICATIONS , vol.15, no.1.
@article{article, author={Mark C. Markowski Et Al. }, title={Bipolar androgen therapy plus nivolumab for patients with metastatic castration-resistant prostate cancer: the COMBAT phase II trial}, journal={NATURE COMMUNICATIONS}, year=2024}